The metabolic syndrome in children and adolescents

Shifting the focus to cardiometabolic risk factor clustering

COMMITTEE ON NUTRITION, SECTION ON ENDOCRINOLOGY, SECTION ON OBESITY

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

Metabolic syndrome (MetS) was developed by the National Cholesterol Education Program Adult Treatment Panel III, identifying adults with at least 3 of 5 cardiometabolic risk factors (hyperglycemia, increased central adiposity, elevated triglycerides, decreased high-density lipoprotein cholesterol, and elevated blood pressure) who are at increased risk of diabetes and cardiovascular disease. The constellation of MetS component risk factors has a shared pathophysiology and many common treatment approaches grounded in lifestyle modification. Several attempts have been made to define MetS in the pediatric population. However, in children, the construct is difficult to define and has unclear implications for clinical care. In this Clinical Report, we focus on the importance of screening for and treating the individual risk factor components of MetS. Focusing attention on children with cardiometabolic risk factor clustering is emphasized over the need to define a pediatric MetS.

Original languageEnglish (US)
Article numbere20171603
JournalPediatrics
Volume140
Issue number2
DOIs
StatePublished - Aug 1 2017

Fingerprint

Cluster Analysis
Pediatrics
Adiposity
Hyperglycemia
HDL Cholesterol
Life Style
Triglycerides
Cardiovascular Diseases
Cholesterol
Blood Pressure
Education
Therapeutics
Population

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

The metabolic syndrome in children and adolescents : Shifting the focus to cardiometabolic risk factor clustering. / COMMITTEE ON NUTRITION, SECTION ON ENDOCRINOLOGY, SECTION ON OBESITY.

In: Pediatrics, Vol. 140, No. 2, e20171603, 01.08.2017.

Research output: Contribution to journalArticle

COMMITTEE ON NUTRITION, SECTION ON ENDOCRINOLOGY, SECTION ON OBESITY 2017, 'The metabolic syndrome in children and adolescents: Shifting the focus to cardiometabolic risk factor clustering', Pediatrics, vol. 140, no. 2, e20171603. https://doi.org/10.1542/peds.2017-1603
COMMITTEE ON NUTRITION, SECTION ON ENDOCRINOLOGY, SECTION ON OBESITY. / The metabolic syndrome in children and adolescents : Shifting the focus to cardiometabolic risk factor clustering. In: Pediatrics. 2017 ; Vol. 140, No. 2.
@article{543ced672fb34349920c6fd91ad9e885,
title = "The metabolic syndrome in children and adolescents: Shifting the focus to cardiometabolic risk factor clustering",
abstract = "Metabolic syndrome (MetS) was developed by the National Cholesterol Education Program Adult Treatment Panel III, identifying adults with at least 3 of 5 cardiometabolic risk factors (hyperglycemia, increased central adiposity, elevated triglycerides, decreased high-density lipoprotein cholesterol, and elevated blood pressure) who are at increased risk of diabetes and cardiovascular disease. The constellation of MetS component risk factors has a shared pathophysiology and many common treatment approaches grounded in lifestyle modification. Several attempts have been made to define MetS in the pediatric population. However, in children, the construct is difficult to define and has unclear implications for clinical care. In this Clinical Report, we focus on the importance of screening for and treating the individual risk factor components of MetS. Focusing attention on children with cardiometabolic risk factor clustering is emphasized over the need to define a pediatric MetS.",
author = "{COMMITTEE ON NUTRITION, SECTION ON ENDOCRINOLOGY, SECTION ON OBESITY} and Magge, {Sheela N.} and Elizabeth Goodman and Armstrong, {Sarah C.} and Stephen Daniels and Mark Corkins and {De Ferranti}, Sarah and Golden, {Neville H.} and Kim, {Jae H.} and Schwarzenberg, {Sarah Jane} and Assar, {Carrie L.} and Jeff Critch and Van Hubbard and Kelley Scanlon and Valery Soto and Debra Burrowes and Sills, {Irene N.} and Casella, {Samuel J.} and DeMeglio, {Linda A.} and Gonzalez, {Jose L.} and Kaplowitz, {Paul B.} and Lynch, {Jane L} and Wintergerst, {Kupper A.} and Laura Laskosz and Bolling, {Christopher F.} and Muth, {Natalie Digate} and Rausch, {John C.} and Rogers, {Victoria Weeks} and Schwartz, {Robert P.} and Goodman, {C. D.R.Alyson} and Mala Thapar",
year = "2017",
month = "8",
day = "1",
doi = "10.1542/peds.2017-1603",
language = "English (US)",
volume = "140",
journal = "Pediatrics",
issn = "0031-4005",
publisher = "American Academy of Pediatrics",
number = "2",

}

TY - JOUR

T1 - The metabolic syndrome in children and adolescents

T2 - Shifting the focus to cardiometabolic risk factor clustering

AU - COMMITTEE ON NUTRITION, SECTION ON ENDOCRINOLOGY, SECTION ON OBESITY

AU - Magge, Sheela N.

AU - Goodman, Elizabeth

AU - Armstrong, Sarah C.

AU - Daniels, Stephen

AU - Corkins, Mark

AU - De Ferranti, Sarah

AU - Golden, Neville H.

AU - Kim, Jae H.

AU - Schwarzenberg, Sarah Jane

AU - Assar, Carrie L.

AU - Critch, Jeff

AU - Hubbard, Van

AU - Scanlon, Kelley

AU - Soto, Valery

AU - Burrowes, Debra

AU - Sills, Irene N.

AU - Casella, Samuel J.

AU - DeMeglio, Linda A.

AU - Gonzalez, Jose L.

AU - Kaplowitz, Paul B.

AU - Lynch, Jane L

AU - Wintergerst, Kupper A.

AU - Laskosz, Laura

AU - Bolling, Christopher F.

AU - Muth, Natalie Digate

AU - Rausch, John C.

AU - Rogers, Victoria Weeks

AU - Schwartz, Robert P.

AU - Goodman, C. D.R.Alyson

AU - Thapar, Mala

PY - 2017/8/1

Y1 - 2017/8/1

N2 - Metabolic syndrome (MetS) was developed by the National Cholesterol Education Program Adult Treatment Panel III, identifying adults with at least 3 of 5 cardiometabolic risk factors (hyperglycemia, increased central adiposity, elevated triglycerides, decreased high-density lipoprotein cholesterol, and elevated blood pressure) who are at increased risk of diabetes and cardiovascular disease. The constellation of MetS component risk factors has a shared pathophysiology and many common treatment approaches grounded in lifestyle modification. Several attempts have been made to define MetS in the pediatric population. However, in children, the construct is difficult to define and has unclear implications for clinical care. In this Clinical Report, we focus on the importance of screening for and treating the individual risk factor components of MetS. Focusing attention on children with cardiometabolic risk factor clustering is emphasized over the need to define a pediatric MetS.

AB - Metabolic syndrome (MetS) was developed by the National Cholesterol Education Program Adult Treatment Panel III, identifying adults with at least 3 of 5 cardiometabolic risk factors (hyperglycemia, increased central adiposity, elevated triglycerides, decreased high-density lipoprotein cholesterol, and elevated blood pressure) who are at increased risk of diabetes and cardiovascular disease. The constellation of MetS component risk factors has a shared pathophysiology and many common treatment approaches grounded in lifestyle modification. Several attempts have been made to define MetS in the pediatric population. However, in children, the construct is difficult to define and has unclear implications for clinical care. In this Clinical Report, we focus on the importance of screening for and treating the individual risk factor components of MetS. Focusing attention on children with cardiometabolic risk factor clustering is emphasized over the need to define a pediatric MetS.

UR - http://www.scopus.com/inward/record.url?scp=85026640246&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85026640246&partnerID=8YFLogxK

U2 - 10.1542/peds.2017-1603

DO - 10.1542/peds.2017-1603

M3 - Article

VL - 140

JO - Pediatrics

JF - Pediatrics

SN - 0031-4005

IS - 2

M1 - e20171603

ER -